Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18812721 | RAPID DETECTION OF KNOWN AND EMERGING INFLUENZA VIRUSES | August 2024 | July 2025 | Abandon | 11 | 3 | 1 | No | No |
| 17634990 | Therapeutic Agent Effectiveness and its Route of Adminstration | February 2022 | September 2025 | Abandon | 43 | 0 | 1 | No | No |
| 17618958 | NOVEL CORONAVIRUS NUCLEIC ACID RAPID HYBRID CAPTURE IMMUNOFLUORESCENCE DETECTION KIT, AND PREPARATION METHOD AND DETECTION METHOD THEREOF | December 2021 | August 2025 | Abandon | 44 | 0 | 1 | No | No |
| 17547317 | METHODS OF PURIFYING ADENOVIRUS | December 2021 | April 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17606792 | RECOMBINANT NOVEL CORONAVIRUS VACCINE USING REPLICATION-DEFICIENT HUMAN ADENOVIRUS AS VECTOR | October 2021 | August 2025 | Abandon | 46 | 1 | 0 | No | No |
| 17604298 | RECOMBINANT CLASSICAL SWINE FEVER VIRUS | October 2021 | May 2025 | Abandon | 43 | 0 | 1 | No | No |
| 17502086 | Intranasal Antiviral Therapy for Mucosal Protection Against Virus Infections | October 2021 | September 2025 | Abandon | 47 | 2 | 0 | No | No |
| 17485824 | VIRUS DETECTION IN WASTEWATER | September 2021 | May 2025 | Abandon | 44 | 1 | 1 | No | No |
| 17461264 | DEVICES AND METHODS FOR DETECTING VIRAL INFECTION | August 2021 | June 2025 | Abandon | 46 | 1 | 1 | No | No |
| 17261802 | NANO ANTIBODY FOR NEUTRALIZING TOXICITY OF SARS-COV-2 AND PREPARATION METHOD AND APPLICATION THEREOF | January 2021 | July 2025 | Allow | 54 | 1 | 1 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner BUCKMASTER, MARLENE VRENI works in Art Unit 1671 and has examined 8 patent applications in our dataset. With an allowance rate of 12.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 46 months.
Examiner BUCKMASTER, MARLENE VRENI's allowance rate of 12.5% places them in the 1% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by BUCKMASTER, MARLENE VRENI receive 0.75 office actions before reaching final disposition. This places the examiner in the 5% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by BUCKMASTER, MARLENE VRENI is 46 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +100.0% benefit to allowance rate for applications examined by BUCKMASTER, MARLENE VRENI. This interview benefit is in the 100% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.